Biomimetic bio-inspired biomorph sustainable? An attempt to classify and clarify biology-derived technical developments.

Over the last few decades, the systematic approach of knowledge transfer from biological concept generators to technical applications has received increasing attention, particularly because marketable bio-derived developments are often described as sustainable. The objective of this paper is to rationalize and refine the discussion about bio-derived developments also with respect to sustainability by taking descriptive, normative and emotional aspects into consideration. In the framework of supervised learning, a dataset of 70 biology-derived and technology-derived developments characterised by 9 different attributes together with their respective values and assigned to one of 17 classes was created. On the basis of the dataset a decision tree was generated which can be used as a straightforward classification tool to identify biology-derived and technology-derived developments. The validation of the applied learning procedure achieved an average accuracy of 90.0%. Additional extraordinary qualities of technical applications are generally discussed by means of selected biology-derived and technology-derived examples with reference to normative (contribution to sustainability) and emotional aspects (aesthetics and symbolic character). In the context of a case study from the building sector, all aspects are critically discussed.

Discovery of two classes of potent glycomimetic inhibitors of Pseudomonas aeruginosa LecB with distinct binding modes.

The treatment of infections due to the opportunistic pathogen Pseudomonas aeruginosa is often difficult, as a consequence of bacterial biofilm formation. Such a protective environment shields the bacterium from host defense and antibiotic treatment and secures its survival. One crucial factor for maintenance of the biofilm architecture is the carbohydrate-binding lectin LecB. Here, we report the identification of potent mannose-based LecB inhibitors from a screening of four series of mannosides in a novel competitive binding assay for LecB. Cinnamide and sulfonamide derivatives are inhibitors of bacterial adhesion with up to a 20-fold increase in affinity to LecB compared to the natural ligand methyl mannoside. Because many lectins of the host require terminal saccharides (e.g., fucosides), such capped structures as reported here may offer a beneficial selectivity profile for the pathogenic lectin. Both classes of compounds show distinct binding modes at the protein, offering the advantage of a simultaneous development of two new lead structures as anti-pseudomonadal drugs with an anti-virulence mode of action.